Home About US Leadership Technology Research News Archive News Archive Newsletter Contact EasyCookieInfo Home About US Leadership Technology Research News Archive News Archive Newsletter Contact Harnessing the Immune System to fight cancer Takis main focus is the development of therapeutic cancer vaccines against tumor antigens which play a role in tumor development and maintenance. Latest News March 2018 - Vaccini Personalizzati Contro Il Cancro, un programma ambizioso 1-3 Feb 2018 - Takis present at 8th meeting on "Advances Against Aspergillosis" New panel for immuno-oncology – available now! 30 Nov - Evvivax and ADNAS announce a collaboration to develop DNA-based vaccines November 14-16 - Takis presented promising data at NeoAntigen Summit in Boston Our team is recognized for the conception and implementation of a number of innovative technologies with the goal to improve in vivo gene transfer, regulation of gene expression and immunogenicity. Our Company Luigi Aurisicchio, PhD Master in "Regulatory Affairs", Chief Executive and Scientific Officer Giuseppe Roscilli, PhD Director, Drug Evaluation and Monoclonal Antibodies. Emanuele Marra Director, Cancer Vaccines and Biomarkers. Takis as a CRO provides a variety of research services in the areas of Oncology, Immunology, Infectious Diseases and novel preclinical models. Send a request Scientific Collaborations Menu Home Takis Leadership Techonology Our Services Takis Biotech Takis Service News Partners Azienda Ospedaliera Biogem Istituto Nazionale Tumori Università Pisa Takis Biotech Harnessing the Immune System to fight cancer. Company About Us Our Mission Research Operation Key expertise Takis S.r.l. Via Castel Romano, 100 00128 Rome - Italy P. I.V.A. 10700711004 Follow us Terms of use Cookie Policy info@takisbiotech.it